MYLK and breast carcinoma: Although this study is looking at different classifications of endothelial dysfunction, such as disorganized hyperproliferation and increased cellular migration, MLCK through ERK signaling has also been implicated in these mechanisms seen with breast cancer cells, and MLCK’s specific inhibitor ML-7 attenuates this effect [52].